Home>Topics>Stocks>C.R. Bard

C.R. Bard

  1. All
  2. Commentary
  3. Stock Reports
  4. Fund Reports
  5. Headlines
  1. Our Top 40 Favorite Dividend Champions

    Headlines

    Wed, 23 May 2012

    Disclosure: Long MKC, JCI, ITW, SYY, JNJ, PG, PEP, GPC, MCD, ITW, MDT, AFL, MHP, ABT, MO, T, KMB, CLX, XOM, BCR at the time of writing. Disclaimer: The opinions in this document are for informational and educational purposes only and should

  2. What's Wrong With Covidien?

    Headlines

    Fri, 4 May 2012

    By Stephen Simpson : You would think that a company posting roughly double the industry average revenue growth rate and solid margins should be one of the more highly-valued companies in the sector. Alas, that's not the case with Covidien ( COV ). While I don't want to leave readers with the ...

  3. Trading Margins For Growth Isn't Going To Help Becton Dickinson

    Headlines

    Thu, 3 May 2012

    By Stephen Simpson : Becton Dickinson ( BDX ) has been a single-digit grower for most of the past decade, and that really hasn't seemed to bother anybody. There's nothing wrong with consistent high-quality performance, particularly when accompanied by improving free cash flow conversion. Although

  4. Medical-device maker C.R . Bard ([[ BCR ]] +1%) names Aramark executive Christopher Holland as its new CFO.

    Headlines

    Tue, 1 May 2012

    Medical-device maker C . R . Bard ( BCR +1% ) names Aramark executive Christopher Holland as its new CFO. Post your comment!

  5. This Stock Has Room For Capital Appreciation And Dividend Growth

    Headlines

    Wed, 25 Apr 2012

    By Furbonacci : Becton, Dickinson and Company ( BDX ) is a worldwide medical technology company with revenues of $7.87 billion. BDX sports a 2.4% forward annual dividend yield with a payout ratio of only 31% , leaving plenty of room for dividend increases. Some of the larger companies in medical ...

  6. CR Bard's CEO Discusses Q1 2012 Results - Earnings Call Transcript

    Headlines

    Wed, 25 Apr 2012

    CR Bard ( BCR ) Q1 2012 Earnings Call April 24, 2012 5:00 pm ET Executives Timothy M. Ring - Chairman, Chief Executive Officer and Chairman

  7. C.R . Bard ( BCR ): Q1 EPS of $1.61 beats by $0.05. Revenue of $730M (+4.2% Y/Y) misses by $3M. Shares +0.6% AH. (PR)

    Headlines

    Tue, 24 Apr 2012

    C . R . Bard ( BCR ): Q1 EPS of $1.61 beats by $0.05 . Revenue of $730M (+4.2% Y/Y) misses by $3M . Shares +0.6% AH. ( PR ) Post your comment!

  8. C.R . Bard , Inc. BCR Q1 2012 Earnings Call Transcript

    Headlines

    Tue, 24 Apr 2012

    Ladies and gentlemen, thank you for standing by. Welcome to the C . R . Bard , Incorporated First Quarter 2012 Earnings Results Conference Call. At this time, all participants are in a listen-only mode

  9. Can Intuitive Surgical Make It To $1,000?

    Headlines

    Wed, 18 Apr 2012

    By Stephen Simpson : There's little question that Intuitive Surgical ( ISRG ) has been one of the all-time great med-tech stocks and arguably has claim to a spot on the all-time list irrespective of industry. Not only has the company managed to drive strong adoption in selected indications, but ...

  10. AngioDynamics Quietly Getting Interesting

    Headlines

    Tue, 10 Apr 2012

    By Stephen Simpson : Although this year is looking a little better than last for med-tech stocks, it's still largely a revenue growth-driven phenomenon. To that end, AngioDynamics' ( ANGO ) unimpressive growth has pushed it towards being an afterthought for many investors. While this story is going

« Prev12345Next »
Content Partners